Published in Int Arch Allergy Appl Immunol on January 01, 1979
Systemic tolerance and secretory immunity after oral immunization. J Exp Med (1980) 3.79
Humoral immune response to oral microorganisms in periodontitis. Infect Immun (1982) 1.28
Use of combined immunization routes in induction of a salivary immunoglobulin A response to Streptococcus mutans in Macaca fascicularis monkeys. Infect Immun (1981) 0.79
Cellular localization of immunoglobulins with different allotypic specificities in rabbit lymphoid tissues. J Exp Med (1965) 6.93
Immunoglobulin allotypes of experimental animals. Prog Allergy (1967) 3.57
Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes. Immunology (1967) 3.33
Immunological analysis of rabbit anti-antibody systems. J Exp Med (1968) 2.84
Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis. J Drug Target (2003) 2.25
Studies on rabbit lymphocytes in vitro. II. Induction of blast transformation with antisera to six IgG allotypes and summation with mixtures of antisera to different allotypes. J Exp Med (1965) 2.25
Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child (1994) 2.13
Demonstration of the exposure of new antigenic determinants following antigen-antibody combination. Nature (1965) 2.04
An allotypic determinant specific to rabbit macroglobulin. Nature (1965) 1.70
Immunoglobulin determinants on the lymphocytes of normal rabbits. 3. As4 and As6 determinants on individual lymphocytes and the concept of allelic exclusion. Immunology (1971) 1.54
Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol (1997) 1.46
Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med (1998) 1.44
Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol (1983) 1.42
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Studies on rabbit lymphocytes in vitro. XI. Superaddition of anti-allotypic lymphocyte transformation: evidence for multipotent lymphoid cells. J Immunol (1970) 1.32
The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response. J Exp Med (1999) 1.29
Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration. Br Med J (1976) 1.28
The proteolytic activity of the major dust mite allergen Der p 1 conditions dendritic cells to produce less interleukin-12: allergen-induced Th2 bias determined at the dendritic cell level. Clin Exp Allergy (2002) 1.28
Technical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.25
Anti-antibodies. Adv Immunol (1967) 1.20
Obstructive jaundice. An unusual presentation of granulocytic sarcoma. Cancer (1987) 1.17
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res (1994) 1.15
Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur J Immunol (1997) 1.15
Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology (1990) 1.15
Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23). Eur J Immunol (1995) 1.14
Immunocytochemical study of Peyer's patches follicular-associated epithelium in the marsupial, Didelphis albiventris. Dev Comp Immunol (1994) 1.14
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer (1994) 1.13
The localization of the different forms of troponin I in skeletal and cardiac muscle cells. Exp Cell Res (1978) 1.10
Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. Infect Immun (1998) 1.10
Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin. Tissue Antigens (1986) 1.09
Delayed hypersensitivity and desensitization to chemical haptens: antigenic specificity of delayed hypersensitivity. Br Med Bull (1967) 1.09
Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol (1988) 1.06
The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol (1988) 1.05
Cellular and molecular events in the delayed-onset hypersensitivities. Rev Physiol Biochem Pharmacol (1978) 1.04
Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology (1981) 1.04
Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol (1998) 1.03
Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo. Drug Deliv (2001) 1.02
Mercury risk from teeth. Nature (1991) 1.01
Calcifying epithelial odontogenic tumour: a case showing features of malignancy. J Oral Pathol (1984) 1.00
The proportion of two b locus allotypic determinants in rabbit antisera raised against pneumococcal polysaccharide SSS 3 antigen. Immunology (1969) 0.99
The protease allergen Der p 1 cleaves cell surface DC-SIGN and DC-SIGNR: experimental analysis of in silico substrate identification and implications in allergic responses. Clin Exp Allergy (2007) 0.99
Surface properties of membrane systems. Transport of staphylococcal delta-toxin from aqueous to membrane phase. Biochim Biophys Acta (1977) 0.99
Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J Antimicrob Chemother (1999) 0.98
The host response to herpes simplex virus. Br Med Bull (1985) 0.96
Immunocytochemical study of the ontogeny of Peyer's patches in the Brazilian marsupial Didelphis albiventris. J Anat (1994) 0.96
Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte. J Gen Virol (1980) 0.95
Immunocytochemical demonstration that human duodenal Brunner's glands may participate in intestinal defence. J Anat (1996) 0.95
Human T cell subset commitment determined by the intrinsic property of antigen: the proteolytic activity of the major mite allergen Der p 1 conditions T cells to produce more IL-4 and less IFN-gamma. Eur J Immunol (2001) 0.95
Inhibition of herpes simplex virus multiplication by activated macrophages: a role for arginase? Infect Immun (1982) 0.95
Mechanism of allotype suppression in the rabbit. Transplant Rev (1975) 0.95
Immunocytochemical study of the ontogeny of the marsupial Didelphis albiventris immune system. J Anat (1995) 0.94
Oral manifestations of inflammatory bowel disease. Clin Gastroenterol (1980) 0.93
Oral manifestations of Crohn's disease: studies in the pathogenesis. Proc R Soc Med (1976) 0.93
Mast cells in human odontogenic cysts. J Oral Pathol Med (1989) 0.92
Immunoglobulin determinants on the lymphocytes of normal rabbits. II. Difficulty in demonstrating the a locus determinants As1, 2 and 3 by the mixed antiglobulin reaction. Immunology (1970) 0.92
The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. Scand J Immunol (1990) 0.92
Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation. Int J Cancer (1995) 0.91
EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. Clin Exp Immunol (1987) 0.91
Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa. Gastroenterology (1998) 0.91
Prevalence of Epstein-Barr virus in the cervix. J Clin Pathol (1994) 0.90
Cytochrome P-450 localization in normal human adult and foetal liver by immunocytochemistry using a monoclonal antibody against human cytochrome P-450. Histochem J (1988) 0.90
The effect of retinal S-antigen-specific monoclonal antibody therapy on experimental autoimmune uveoretinitis (EAU) and experimental autoimmune pinealitis (EAP). Clin Exp Immunol (1989) 0.90
IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin. Br J Cancer (1986) 0.90
Delayed hypersensitivity: specific cell-mediated immunity. Br Med Bull (1967) 0.89
The proteolytic activity of the major dust mite allergen Der p 1 enhances the IgE antibody response to a bystander antigen. Clin Exp Allergy (2001) 0.89
The natural antibody response to E. coli includes antibodies of the IgD class. Clin Exp Immunol (1978) 0.89
Investigation of the expression of IL-1beta converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages. Clin Exp Immunol (1999) 0.89
Intra-abdominal sepsis: an immunocytochemical study of the small intestine mucosa. J Clin Pathol (1997) 0.88
Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A. Immunology (1988) 0.88
Survey of the use of personal protective equipment and prevalence of work related symptoms among dental staff. Occup Environ Med (1997) 0.88
Production of cell-mediated immune response to herpes simplex virus by immunization with anti-idiotypic heteroantisera. J Gen Virol (1985) 0.88
Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues. Immunology (1987) 0.87
Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: an immunohistochemical and flow cytometric analysis. J Autoimmun (1990) 0.87
Oxygen-dependent leishmanicidal activity of stimulated macrophages. Mol Cell Biochem (1996) 0.87
Autoantibody to nerve tissue in a patient with a peripheral neuropathy and an IgG paraprotein. J Clin Pathol (1981) 0.86
Primary sequence and molecular model of the variable region of a mouse monoclonal anti-Der p 1 antibody showing a similar epitope specificity as human IgE. Clin Exp Allergy (1998) 0.86
The use of phage-peptide libraries to define the epitope specificity of a mouse monoclonal anti-Der p 1 antibody representative of a major component of the human immunoglobulin E anti-Der p 1 response. Clin Exp Allergy (1999) 0.86
Histological and ultrastructural studies of the marsupial Didelphis albiventris Peyer's patches. Mem Inst Oswaldo Cruz (1992) 0.86
Effects of modulating erythrocyte membrane cholesterol on Rho(D) antigen expression. Biochem Biophys Res Commun (1980) 0.85
Atrophoderma of Pasini and Pierini. An immunopathologic case study. Am J Clin Pathol (1992) 0.85
A sensitive fluorescent assay for measuring the cysteine protease activity of Der p 1, a major allergen from the dust mite Dermatophagoides pteronyssinus. Mol Pathol (1998) 0.85
A novel peptide-grafted liposomal delivery system targeted to macrophages. Antimicrob Agents Chemother (1998) 0.85
Modulation of macrophage mannose receptor affects the uptake of virulent and avirulent Leishmania donovani promastigotes. J Parasitol (2001) 0.85
Induction of specific anti-guinea pig T cell sera in rabbits. J Immunol Methods (1976) 0.85
Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Biomed Pharmacother (2001) 0.85
Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG). J Parasitol (1996) 0.84
Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation. Clin Exp Immunol (1986) 0.84
Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania. Biochem J (1999) 0.83
Isolation and characterization of plamsa membrane from monolayer cultures of epitherlial type II lung cells. Arch Biochem Biophys (1979) 0.83
Separation by column chromatography of cells active in delayed-onset hypersensitivities. Immunology (1976) 0.83
Cellular and immunological aspects of delayed hypersensitivity. Ann N Y Acad Sci (1970) 0.82
Immunocytochemistry of mucosal changes in patients infected with the intestinal nematode Strongyloides stercoralis. J Clin Pathol (1996) 0.82
Reaction of monoclonal anti Leu M1--a myelomonocytic marker (CD15)--with normal and neoplastic epithelia. J Pathol (1987) 0.82
Studies on rabbit lymphocytes in vitro. XVI. Restimulation of antiallotypically stimulated and blocked cultures. J Immunol (1973) 0.82
Generation of large granular lymphocytes and lymphocyte subset changes linked with cyclophosphamide-induced eosinophilia in rats--and the effects of ciclosporin. Scand J Immunol (1987) 0.82
pH, temperature, humidity and the dynamic force-area curve of dipalmitoyl lecithin. Respir Physiol (1976) 0.82